2021
DOI: 10.1016/j.jcjd.2020.08.109
|View full text |Cite
|
Sign up to set email alerts
|

Strategies to Overcome Therapeutic Inertia in Type 2 Diabetes Mellitus: A Scoping Review

Abstract: Therapeutic inertia in the management of type 2 diabetes mellitus is common, with causes at the patient, health-care professional and health-care system levels. The majority of recent strategies to address therapeutic inertia usually consisted of multiple interventions, but rarely targeted more than 1 level. Most strategies used educational interventions among patients or health-care professionals, but gaps were found in addressing determinants of behaviour change.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
9
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 67 publications
(18 reference statements)
0
9
0
1
Order By: Relevance
“…A review performed by Wrzal et al [ 130 ] showed how in-person education is still the most relevant approach toward patients and between clinicians (54%), while technology still has a secondary role, with e-learning (14%), electronic medical records (8%), or mobile applications (18%). Interestingly, no educational intervention has focused on explaining the drugs’ side effects to the patients or reassuring them about the risk of hypoglycemia, rather showing a conservative approach of clinicians to therapeutic decisions.…”
Section: Future Perspectives For Dkd-related Therapeutical Inertia Managementmentioning
confidence: 99%
See 2 more Smart Citations
“…A review performed by Wrzal et al [ 130 ] showed how in-person education is still the most relevant approach toward patients and between clinicians (54%), while technology still has a secondary role, with e-learning (14%), electronic medical records (8%), or mobile applications (18%). Interestingly, no educational intervention has focused on explaining the drugs’ side effects to the patients or reassuring them about the risk of hypoglycemia, rather showing a conservative approach of clinicians to therapeutic decisions.…”
Section: Future Perspectives For Dkd-related Therapeutical Inertia Managementmentioning
confidence: 99%
“…Interestingly, no educational intervention has focused on explaining the drugs’ side effects to the patients or reassuring them about the risk of hypoglycemia, rather showing a conservative approach of clinicians to therapeutic decisions. The main outcomes measured in the intervention group were improved glycated hemoglobin levels, a higher proportion of intensified therapies with insulin or GLP-1-RA, or better results in the knowledge tests provided [ 130 ].…”
Section: Future Perspectives For Dkd-related Therapeutical Inertia Managementmentioning
confidence: 99%
See 1 more Smart Citation
“…9 10 Reasons for the delay of treatment intensification are multifaceted, 7 11 12 and effective interventions targeting barriers to insulin use are required. [13][14][15] At a systemic or health professional level, promising results have been shown using multidisciplinary models of care (eg, an enhanced practice nurse role within primary care setting 9 ), effective consultation strategies (eg, collaborative approach to care 16 ) and insulin-specific structured education programmes. 17 18 However, there is a parallel need for interventions, which directly target the psychological barriers (negative beliefs and attitudes) to insulin held by the person with T2D.…”
Section: Introductionmentioning
confidence: 99%
“…Clinician-related factors include ever-evolving guidelines and treatment goals, new treatment options, formulary and insurance restrictions, time constraints during patient visits, clinicianpatient communication issues, complexities in patient disease management resulting from multiple comorbid diseases, concerns about adverse events and treatment complexity, and lack of a multidisciplinary diabetes care team (16)(17)(18)(19). Lack of knowledge regarding evolving evidence-based treatment and inability to confidently integrate this knowledge into clinical practice are key barriers to improving clinician factors that contribute to therapeutic inertia (20).…”
mentioning
confidence: 99%